Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis
Clinical trial NCT01701856 · TERMINATED
Trial details
- NCT number
- NCT01701856
- Sponsor
- Claudio Gobbi
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2013-10-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.